by Stacey Johnson | Jun 7, 2019
Australian culture and pride were very much on display at ISCT 2019, the annual meeting of clinicians, regulators, researchers, technologists and industry who claim membership in the International Society for Cell and Gene Therapy (ISCT). While it was my first time...
by Erika Siren | Jan 23, 2019
September 5th, 2018, marked a momentous day for Canadian health care as Novartis announced Health Canada’s approval of Kymriah™, the first genetically manipulated cell therapy to be approved in Canada. With the ability of CAR Ts like Kymriah to treat and, potentially...
by Sowmya Viswanathan | Jun 26, 2018
Debe Griffin, MSc, ASQ CPGP, has over 20 years of experience in the cell therapy field, both in bench positions and in leadership. Her primary interests are process improvement, quality assurance and regulatory affairs. She is a consultant with FACT Consulting...
by Sowmya Viswanathan | Jun 19, 2018
Debe Griffin, MSc, ASQ CPGP, has over 20 years of experience in the cell therapy field, both in bench positions and in leadership. Her primary interests are process improvement, quality assurance and regulatory affairs. She is a consultant with FACT Consulting...
Comments